Delivery Order SPE2DB20D2001-SPE2DB25FPNHK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Tacrolimus 0.1% Ointment in 100-gram units, with a ceiling value of $1,132.80 and a firm fixed price structure. This award was made without a set-aside designation, indicating open competition. The delivery order is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 60 gram tubes of 0.1% Tacrolimus ointment. The contract has a potential value of $13,556.26 and a completion date of March 29, 2022. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Tacrolimus 0.1% ointment. The award has a ceiling value of $9,430.50 and a period of performance through April 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering pharmaceutical products...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corporation, a subsidiary of the parent company Cencora, Inc. The $2,170.57 award is for the delivery of Tacrolimus 0.1% ointment, a pharmaceutical product used to treat certain medical conditions. No set-aside designation was used for this contract. Amerisourcebergen Drug Corporation holds an indefinite delivery contract (IDC) with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,078.16 firm fixed-price contract is for the supply of TACROLIMUS 0.03% OINTMENT 60GM, with a period of performance through May 9, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tacrolimus 5 mg capsules (immediate release) in quantities of 100 units. The contract, valued at $67,741.38, was competitively awarded on July 18, 2025, with an ultimate completion date of July 21, 2025. This delivery order employs firm fixed pricing and carries no set-aside designation. AmerisourceBergen will perform the work at its corporate headquarters in...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Tacrolimus 0.1% ointment, a prescription medication, to the U.S. government. The firm-fixed-price delivery order, valued at $6,966.50, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency. The contract has no set-aside designation and is intended to support the DLA's mission of providing logistics, acquisition, and technical services to the U.S. Armed Forces...
- The Defense Logistics Agency awarded a $79,560 firm fixed price delivery order to Amerisourcebergen Drug Corporation for tacrolimus 0.1% ointment. As the prime contractor, Amerisourcebergen will deliver 30 grams of the prescribed ointment to an agency location in Conshohocken, Pennsylvania by August 3, 2023 under the terms of the order. The single award was made against an existing DLA contract vehicle but no further contract details were provided. Amerisourcebergen, a subsidiary of...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order valued at $2,690.81 with a Firm Fixed Price pricing type. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Tacrolimus 0.1% Ointment 60GM, a specialty medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TACROLIMUS .1% OINT 1S, a pharmaceutical product, with a ceiling value of $14,406.22 and an ultimate completion date of August 29, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNHKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,809.30 to AmerisourceBergen Drug Corp for Tacrolimus 0.1% ointment in 30-gram units, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 through December 2026. The prime IDV functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/29/25 |